Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
NewAmsterdam Pharma, headquartered in the Netherlands, is a biopharmaceutical company specializing in the development of innovative therapies for cardiovascular diseases. Its core focus is the treatment of patients who are at high risk of experiencing serious cardiovascular complications and related conditions.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
NewAmsterdam Pharma is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
NewAmsterdam Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.52 USD.
Across its last 3 earnings reports, NewAmsterdam Pharma stock moved by ±4.8% on average the following day. The largest reaction was +12.5% on 05/07/2026; 2 of 3 reactions were positive.
NewAmsterdam Pharma has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.